Alka-Seltzer Plus Cold Sparkling Original
NDC 0280-1520, Aspirin, Chlorpheniramine maleate, Phenylephrine bitartrate, tablet, effervescent, from Bayer HealthCare LLC..
- Product NDC
- 0280-1520
- Status
- Listed
- Labeler
- Bayer HealthCare LLC.
- Dosage form
- TABLET, EFFERVESCENT
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M012
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0280-1520 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ASPIRIN325 mg/1
- PHENYLEPHRINE BITARTRATE7.8 mg/1
- CHLORPHENIRAMINE MALEATE2 mg/1
Pharmacologic classes
Adrenergic alpha1-Agonists [MoA]; Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Decreased Platelet Aggregation [PE]; Decreased Prostaglandin Production [PE]; Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]; Nonsteroidal Anti-inflammatory Drug [EPC]; Platelet Aggregation Inhibitor [EPC]; alpha-1 Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0280-1520-04 | 00280152004 | 2 POUCH in 1 CARTON (0280-1520-04) / 2 TABLET, EFFERVESCENT in 1 POUCH |
| 0280-1520-20 | 00280152020 | 10 POUCH in 1 CARTON (0280-1520-20) / 2 TABLET, EFFERVESCENT in 1 POUCH |
| 0280-1520-36 | 00280152036 | 18 POUCH in 1 CARTON (0280-1520-36) / 2 TABLET, EFFERVESCENT in 1 POUCH |
| 0280-1520-48 | 00280152048 | 24 POUCH in 1 CARTON (0280-1520-48) / 2 TABLET, EFFERVESCENT in 1 POUCH |
| 0280-1520-72 | 00280152072 | 36 POUCH in 1 CARTON (0280-1520-72) / 2 TABLET, EFFERVESCENT in 1 POUCH |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 0280-1520 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0280-1520 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0280-1520. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.